Results 1 - 10 of 106
- Latest perspectives of orally bioavailable 2,4-diarylaminopyrimidine analogues (DAAPalogues) as anaplastic lymphoma kinase inhibitors: discovery and clinical developments. Muhammad Latif, Zaman Ashraf, Sulman Basit, Abdul Ghaffar, Muhammad Sohail Zafar, Aamer Saeed, Sultan Ayoub Meo
, RSC Adv.
, 2018
, 8
, 16470
- Anaplastic lymphoma kinase (ALK) inhibitors: a review of design and discovery. Wen-Chieh Wang, Hui-Yi Shiao, Chieh-Chien Lee, Ka-Shu Fung, Hsing-Pang Hsieh
, Med. Chem. Commun.
, 2014
, 5
, 1266
- Metastasis manners and the underlying mechanisms of ALK and ROS1 rearrangement lung cancer and current possible therapeutic strategies. Xing Chang, Zi Liu, Shuai Man, Annie Roys, Zengqiang Li, Daiying Zuo, Yingliang Wu
, RSC Adv.
, 2019
, 9
, 17921
- Identification of mitoxantrone as a new inhibitor of ROS1 fusion protein in non-small cell lung cancer cells. Lian-Xiang Luo, Xing-Xing Fan, Ying Li, Xia Peng, Yin-Chun Ji, Wendy Wen-Luan Hsiao, Liang Liu, Elaine Lai-Han Leung, Xiao-Jun Yao
, Med. Chem. Commun.
, 2017
, 8
, 621
- Kinase inhibitor macrocycles: a perspective on limiting conformational flexibility when targeting the kinome with small molecules. Baku Acharya, Debasmita Saha, Daniel Armstrong, Baha'a Jabali, Maha Hanafi, Alan Herrera-Rueda, Naga Rajiv Lakkaniga, Brendan Frett
, RSC Med. Chem.
, 2024
, 15
, 399
- Design, synthesis and biological evaluation of novel amide-linked 18β-glycyrrhetinic acid derivatives as novel ALK inhibitors. Dong Cai, Zhi hua Zhang, Yu Chen, Chao Ruan, Sheng qiang Li, Shi qin Chen, Lian shan Chen
, RSC Adv.
, 2020
, 10
, 11694
- Identification of a potent kinase inhibitor targeting EML4-ALK fusion protein in non-small cell lung cancer. Lian-Xiang Luo, Ying Li, Yu-Zhen Niu, Yu-Wei Wang, Qian-Qian Wang, Xing-Xing Fan, Jia-Hui Xu, Liang Liu, Elaine Lai-Han Leung, Xiao-Jun Yao
, Med. Chem. Commun.
, 2017
, 8
, 1914
- The synthesis of Bcr-Abl inhibiting anticancer pharmaceutical agents imatinib, nilotinib and dasatinib. Benjamin J. Deadman, Mark D. Hopkin, Ian R. Baxendale, Steven V. Ley
, Org. Biomol. Chem.
, 2013
, 11
, 1766
- A time-resolved luminescence biosensor assay for anaplastic lymphoma kinase (ALK) activity. Wei Cui, Laurie L. Parker
, Chem. Commun.
, 2015
, 51
, 362
- Near infrared imaging of Mer tyrosine kinase (MERTK) using MERi-SiR reveals tumor associated macrophage uptake in metastatic disease. Miles A. Miller, Eunha Kim, Michael F. Cuccarese, Alec L. Plotkin, Mark Prytyskach, Rainer H. Kohler, Mikael J. Pittet, Ralph Weissleder
, Chem. Commun.
, 2018
, 54
, 42